US Patent 9315811 Methods for modulating kallikrein (KLKB1) expression
Patent 9315811 was granted and assigned to Ionis Pharmaceuticals on April, 2016 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9315811 Methods for modulating kallikrein (KLKB1) expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
